Fig. 1: OS and TTF in the Full Analysis Set (FAS) population.

Comparison of OS a and TTF b between placebo-treated (black line) and Vx-001 treated (blue line) patients.

Comparison of OS a and TTF b between placebo-treated (black line) and Vx-001 treated (blue line) patients.